Our investment team includes:
NinePoint Medical, Inc. is a privately-held medical device company located in Bedford, MA.
Press Releases
2018
2017
- October 23, 2017 New Clinical Data Presented at the World Congress of Gastroenterology @ ACG 2017 Shows Increased Dysplasia Detection Using Volumetric Laser Endomicroscopy with Laser Marking
- May 5, 2017 NinePoint Medical to Feature the NvisionVLE® Imaging System with Real-time TargetingTM at DDW 2017; Twenty-four Scientific Abstracts to be Presented
2016
- Nov. 15, 2016 NinePoint Medical Announces Substantial Hospital Reimbursement Increase for Procedures Using the NvisionVLE® Imaging System with Real-time Targeting™.
- Oct. 15, 2016 New Clinical Data using the NvisionVLE® Imaging System to be presented at ACG 2016 and UEGW 2016.
- May. 19, 2016 NinePoint Medical Announces Completion of Clinical Registry and Publication of Results at DDW 2016.
- May. 10, 2016 NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.
- May. 03, 2016 NinePoint Medical Strengthens Sales Leadership by appointing John Temple as Vice President of Sales
2015
2014
- Dec. 4, 2014 NinePoint Medical Appoints Christopher von Jako, PhD, to Chief Executive Officer
- June 12, 2014 NinePoint Medical Receives 2014 MDEA Silver Medal for NvisionVLE Imaging System
- April 30, 2014 New Clinical Data using the NvisionVLE® Imaging System to be presented at Digestive Disease Week® 2014
- March 20, 2014 NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE® Imaging System
2013
- May 21, 2013 NinePoint Medical Presents New Clinical Data on NvisionVLE® at Digestive Disease Week
- May 16, 2013 NinePoint Medical Announces U.S. Commercial Availability of the NvisionVLE® Imaging System
- May 13, 2013 NinePoint Medical to Present NvisionVLE® Clinical Data at Digestive Disease Week 2013
- Apr. 26, 2013 NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE® Imaging System
- Mar. 20, 2013 NinePoint Medical Imaging Technology Profiled in Three Recent Publications
- Jan. 17, 2013 NinePoint Medical Imaging Technology Highlighted in Nature Medicine Publication
2012
- Oct. 2, 2012 NinePoint Medical Continues to Strengthen Leadership Team with Two New Members; Also Selected to 2012 “Fierce 15” List of Innovative Companies by FierceMedicalDevices Company Appoints Chief Financial Officer and Vice President of Sales
- Jun. 6, 2012 NinePoint Medical Receives European CE Mark Approval and ISO Certification
- May 11, 2012 NinePoint Medical to Unveil NvisionVLE® Imaging System at DDW 2012
- Feb. 22, 2012 NinePoint Medical Initiates Clinical Trial of Nvision VLE Imaging System; Program On Track for Commercial Launch in 2013
- Feb. 1, 2012 NinePoint Medical Announces Formation of Clinical and Technology Advisory Boards
- Jan. 5, 2012 NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System
2011
2010
- Dec. 13, 2010 NinePoint Medical Licenses 188 Patents and Patent Applications; Patents Support NinePoint’s Broad-Based Platform Technology for Development of in vivo Pathology Devices
- Nov. 3, 2010 NinePoint Medical Awarded Qualifying Therapeutic Discovery Project Program Grant
- Oct. 15, 2010 NinePoint Medical Adds Optical Coherence Tomography Technology Expert to Board of Directors
- Oct. 14, 2010 NinePoint Medical Completes $33 Million Series A Financing to Develop Innovative Broad-Based Medical Platform for in vivo Pathology Devices
